Abstract:Globally, about 71 million people have chronic HCV infection. A significant number of those who are chronically infected will develop cirrhosis or liver cancer. Approximately 399, 000 person die every year from liver cirrhosis and hepatocellular carcinoma. Liver fibrosis reflects sustained liver injury often from multiple, simultaneous factors. Assessment of the effect of antiviral treatment on liver fibrosis is desirable end point for evaluation of the efficacy of therapy. To validate and compare the diagnostic performance of RDW to Platelet ratio for prediction of liver fibrosis before and after antiviral treatment in patient with chronic HCV infection. In Comparison with other markers of fibrosis (fib-4, APRI) scores and fibroscan. This study was conducted on 50 adult patients with chronic hepatitis C virus subdivided into two groups. First group: 25 Non cirrhotic patients having chronic HCV infection. Second group: 25 Cirrhotic CHILD A patients having chronic HCV infection and followed up in Gastroenterology out patient’s clinic, Al Demerdash Hospital, Ain Shams University. The results obtained can be summarized as follows: RDW/PLT can predict liver fibrosis and cirrhosis with agood degree of accuracy before HCV treatment. RDW/PLT can predict liver cirrhosis (F3 & F4) with an excellent degree of accuracy after HCV treatment. RDW/PLT cannot predict early liver fibrosis (F1 & F2) after HCV treatment as results assuming apoor degree of accuracy. According to above results RDW/PLT can be used instead of liver biopsy to detect degree of liver fibrosis and cirrhosis before HCV treatment with agood degree of accuracy. While after HCV treatment we can depend on RDW/PLT to predect degree of advanced liver fibrosis and cirrhosis (F3 & F4) with an excellent degree of accuracy. But we need further studies on RDW/PLT to detect the accuracy of prediction of early liver fibrosis (F1 & F2) after HCV treatment. RDW/PLT can predict liver fibrosis and cirrhosis with agood degree of accuracy before HCV treatment. RDW/PLT can predict liver cirrhosis (F3 & F4) with an excellent degree of accuracy after HCV treatment. RDW/PLT cannot predict early liver fibrosis (F1 & F2) after HCV treatment as results assuming apoor degree of accuracy. According to above results RDW/PLT can be used instead of liver biopsy to detect degree of liver fibrosis and cirrhosis before HCV treatment with agood degree of accuracy. While after HCV treatment we can depend on RDW/PLT to predect degree of advanced liver fibrosis and cirrhosis (F3 & F4) with an excellent degree of accuracy. But we need further studies on RDW/PLT to detect the accuracy of prediction of early liver fibrosis (F1 & F2) after HCV treatment.

Platelets-to-lymphocyte Ratio As a Predictor of Liver Fibrosis and Insulin Resistance in Hepatitis C Virus Infection: More Evidence is Needed

Predictive Value of the Red Blood Cell Distribution Width-to-platelet Ratio for Hepatic Fibrosis.

Insulin Resistance is a Risk Factor for Esophageal Varices in Hepatitis C Virus Cirrhosis

Plateletcrit As a Potential Index for Predicting Liver Fibrosis in Chronic Hepatitis B

Acoustic Radiation Force Impulse in the Diagnosis of Liver Fibrosis in Patients with Chronic Hepatitis B

Reply to the letter by Beyan et al "Plateletcrit may not be an index for predicting of liver fibrosis in patients with chronic hepatitis B".

Development and Validation of a Non-Invasive Model for Predicting Liver Cirrhosis in Patients with Chronic Hepatitis B

Predictive Performances of Blood Parameter Ratios for Liver Inflammation and Advanced Liver Fibrosis in Chronic Hepatitis B Infection

Neutrophil-lymphocyte ratio and mean platelet volume as predictive factors for liver fibrosis and steatosis in patients with chronic hepatitis B

RDW, NLR and RLR in Predicting Liver Failure and Prognosis in Patients with Hepatitis E Virus Infection.

Development and validation of a novel score for fibrosis staging in patients with chronic hepatitis B.

Low platelets: a new and simple prognostic marker for patients with hepatitis E virus-related acute liver failure

Rdw To Platelet Ratio: A Novel Noninvasive Index For Predicting Hepatic Fibrosis And Cirrhosis In Chronic Hepatitis B

INR-to-platelet ratio (INPR) as a novel noninvasive index for predicting liver fibrosis in chronic hepatitis B

Red cell distribution width to platelet ratio predicts liver fibrosis in patients with autoimmune hepatitis.

Red cell distribution width to platelet ratio (RPR) predicts liver fibrosis in patients with autoimmune hepatitis

Platelet Count and Prediction of Bleeding in Patients with Liver Cirrhosis

Evaluation of Red Cell Distribution Width (RDW) to Platelet Ratio as a Novel Non-Invasive Index for Predicting Hepatic Fibrosis in Patients with Chronic Hepatitis C before and after Antiviral Treatment

Serum Platelet-Derived Growth Factor BB Levels: a Potential Biomarker for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B.

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

Model for end-stage liver disease-dependent prognostic capacity of platelet-to-lymphocyte ratio following liver transplantation for hepatocellular carcinoma